Boosting pancreatic cancer chemotherapy via nerve–cancer crosstalk
www.scienceopen.com/hosted-docum...
#PancreaticCancer #Chemotherapy #TumorMicroenvironment #Neurobiology #CancerTherapeutics
0
0
0
0
Hashtag
#CancerTherapeutics
Advertisement · 728 × 90
Antineoplastic effects of icaritin
www.scienceopen.com/hosted-docum...
#Icaritin #Antineoplastic #NaturalCompounds #CancerTherapeutics #DrugDevelopment
0
0
0
0
Exploring advances in Cancer Therapeutics, Targets & Resistance from Acta Materia Medica
Discover cutting-edge research: amm-journal.org
#CancerResearch #CancerTherapeutics #DrugResistance #Oncology
0
0
8
0
In a new study in Science Translational Medicine, utilizes epigenomic mapping with EpiCypher's CUTANA™ CUT&RUN revealing a new combo therapy for aggressive pediatric brain tumors.
🔗Read more: www.science.org/doi/10.1126/scitranslmed...
#Epigenetics #ChromatinBiology #CancerTherapeutics
2
1
0
0
RESEARCH PAPER: ERRγ impedes neuroendocrine prostate cancer development
By Li et al., and Vincent Giguère
➡️ https://genesdev.cshlp.org/content/40/3-4/160.abstract
Vincent Giguère
#prostatecancer #neuroendocrine #cancertherapeutics #nuclearreceptor
0
0
0
0
This review provides insights into #SilverNanoparticles as #CancerTherapeutics, showing how tuning shapes biodistribution, #radiosensitization, & multimodal synergy, with imaging‑guided design & safety for patient‑specific #nanomedicine.
Nanotechnology Reviews: doi.org/10.1515/ntre...
0
0
0
0
Targeting CD155 in lung adenocarcinoma with a nanobody-based therapy
A5 nanobody targeting CD155 shows promise for selective therapeutic intervention in lung adenocarcinoma.
doi.org/10.1038/s413...
#LungAdenocarcinoma #Nanobody #CD155 #CancerTherapeutics
0
0
0
0
🆕 ADVANCE ONLINE 🆕
RESEARCH PAPER: ERRγ impedes neuroendocrine prostate cancer development
By Li et al., and Vincent Giguère
➡️ genesdev.cshlp.org/content/early/2025/10/29...
#prostatecancer #neuroendocrine #cancertherapeutics #nuclearreceptor
0
0
0
0
Integrating spatial analysis in the study of silver nanoparticles for radiotherapy: from molecular mechanisms to bio distribution in biological systems
This review provides insights into #SilverNanoparticles as #CancerTherapeutics, showing how tuning shapes biodistribution, #radiosensitization, & multimodal synergy, with imaging‑guided design & safety for patient‑specific #nanomedicine.
Nanotechnology Reviews: doi.org/10.1515/ntre...
0
0
0
0
Targeting the STARD4/EGFR axis inhibits HCC growth & overcomes lenvatinib resistance.
#HCC #DrugResistance #EGFR #CancerTherapeutics #Lenvatinib
www.sciencedirect.com/science/arti...
0
0
0
0
Integrating spatial analysis in the study of silver nanoparticles for radiotherapy: from molecular mechanisms to bio distribution in biological systems
This review examines #AgNPs as #CancerTherapeutics, showing how physicochemical tuning controls biodistribution, #radiosensitization, and multimodal synergy, while addressing imaging, safety, and clinical translation in #nanomedicine.
Nanotechnology Reviews: doi.org/10.1515/ntre...
0
0
0
0
Comprehensive overview of how diverse viruses contribute to cancer development and the therapeutic opportunities emerging from these mechanisms.
#ViralOncogenesis #CancerMechanisms #TumorVirology #CancerTherapeutics
www.nature.com/articles/s41...
0
0
0
0
Cutting-edge phototherapy approaches are transforming cancer treatment, though key challenges remain in delivery, targeting, and resistance.
#Phototherapy #CancerTreatment #LightBasedTherapy #OncologyInnovation #CancerTherapeutics
www.nature.com/articles/s41...
1
0
1
0
Innate immune sensors and pathways are driving innovative cancer therapies, reshaping how early immune responses can be therapeutically tuned.
#InnateImmunity #CancerTherapeutics #PatternRecognition #ImmuneActivation #CancerImmunology
www.nature.com/articles/s41...
0
0
1
0
Calling cancer researchers! 🚀
🔬 Basic&Mechanistic Research
🧬 Translational&Clinical Oncology
💊 Technology & Interdisciplinary Innovations
APCs are fully waived 2025 to 2027！
🌟Submit Manuscript：
jms.elspub.com/login
#CallForPapers #OpenAccess #CancerResearch #Oncology #CancerTherapeutics
2
0
0
0
Transforming #CancerTherapeutics from pathways to patients. Join the 2026 Cancer Series to explore cancer from every angle and shape the future of #CancerMedicine. Connect insights in #TumorMicroenvironment, #TumorMetabolism & #CancerImmunotherapy. keypoint.keystonesymposia.org/home/transfo...
2
1
0
0
New research reveals VER inhibits #Osteosarcoma growth by blocking the #PI3K/#AKT pathway both in vitro and in vivo, positioning it as a promising #therapeutic candidate for OS treatment. #DrugDiscovery #CancerTherapeutics #medsky
#OpenAccess: www.sciencedirect.com/science/arti...
1
1
0
0
Congratulations to our UCAN Ireland members @miriamstaunton.bsky.social & @cynthiacravo.bsky.social on becoming EUPATI Fellows 🎉
A wonderful achievement and testament of your dedication to patient advocacy👏👏👏
#ExpertPatientVoices #CancerTherapeutics #Innovation #EUPATI
2
2
0
0
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond
@tamedoncol.bsky.social
@linglingtian.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#precisiononcology #cancertherapeutics #medicine #openaccess
1
0
0
0
Check out research into novel MOF-based biomaterials in the latest issue of Biomaterials Science:
🧪 doi.org/10.1039/D5BM...
🧪 doi.org/10.1039/D5BM...
#MOFs #Biomaterials #CancerTherapeutics
3
2
0
0
🚨 Registration is now open!
Join us in Boston this October for a dynamic one-day conference focused on #MappingBiology and transforming #CancerTherapeutics. Visit the website to explore topics, confirmed speakers, and talk opportunities
🔗 abcam.me/mappingbiolo...
0
0
0
0
Join me in Boston October 6th for a 1-day conference on #mappingbiology to transform #cancertherapeutics. Register by September 25th to benefit from the complimentary (free) admission! Topics, speakers, and talk opportunities here: abcam.me/mappingbiolo...
@abcamofficial.bsky.social
7
4
0
0
Amplia has announced that it has received Australian ethics approval for the Ph2 trial of narmafotinib in combination with FOLFIRINOX in advanced pancreatic cancer.
Read the ASX release: bit.ly/ATX_AU_Ethics
$ATX #Amplia #clinicaltrials #pancreaticcancer #cancertherapeutics
0
0
0
0
Amplia Therapeutics has announced 17th confirmed partial response (PR) has been recorded in the Company’s ongoing ACCENT clinical trial in pancreatic cancer. Read the ASX release: bit.ly/ATX_17th_PR
#pancreaticcancer #clinicaltrial #cancertherapeutics #oncology #pharma #biotech #ASX
0
0
0
0
New publication from Wayne State EACPHS explores indole-carboxamide derivatives as selective anticancer agents with strong molecular docking hits on EGFR and topoisomerase. Promising leads, especially compound 10.
🔗 doi.org/10.3390/ijms...
#CancerTherapeutics #DrugDesign
0
0
0
0
#Amplia has announced that a second patient enrolled in the ACCENT trial has recorded a confirmed complete response (CR). Read the ASX release tinyurl.com/33ez5srv
#pancreaticcancer #clinicaltrial #cancertherapeutics #oncology #pharma #biotech #ASX
1
0
0
1
🧫 Meet Dr. Jim Hurley, 2025 MTI Innovator Awardee!
His lab is unlocking the druggable potential of the ESCRT system - an essential pathway once considered too complex to target in cancer.
From deep structural biology to novel screens, this is drug discovery done differently.
#MTI #CancerTherapeutics
1
0
0
0
Kairos Pharma Secures $3.5 Million in PIPE Financing to Accelerate Growth
www.linkedin.com/pulse/kairos...
kstrategyand.com/pharma-news
#KairosPharma #PIPEFinancing #CancerResearch #PharmaceuticalGrowth #CancerTherapeutics #InvestmentDeal #BiotechInnovation #Humanteconomy #Humantec #KStrategyand
0
0
0
0
Interesting perspective on key considerations for sponsors and investigators pursuing dose optimization with combinatorial regimens @oncoalert.bsky.social #CancerTherapeutics #DrugDevelopment #Synergy
5
1
0
0